Reduced toxoplasmastatic activity of monocytes from AIDS patients: A role for granulocyte-macrophage colony-stimulating factor

Scandinavian Journal of Immunology

Volumn 47, Issue 2, 1998, Pages 163-166

  Delemarre, F G A ^a,b   Stevenhagen, A ^a   Kroon, F P ^a   Van Furth, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; POLYCLONAL ANTIBODY; PROSTAGLANDIN E2; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIPROTOZOAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANIMALS; CELLS, CULTURED; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED CBA; MIDDLE AGED; MITOGENS; MONOCYTES; RABBITS; TOXOPLASMA;

EID: 0031889356     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jaffe HW, Bregman D, Selik RM. Acquired immune deficiency syndrome in the United States: The first 1000 cases. J Infect Dis 1983;148:339-45.
2. Delemarre FGA, Stevenhagen A, Snijders F et al. Restoration of the toxoplasmastatic activity of monocytes from AIDS patients during in vivo treatment with interferon-γ. J Infect Dis 1993;168:516-8.
3. Delemarre FGA, Stevenhagen A, Kroon FP, van Eer MY, Meenhorst PL, van Furth R. Effect of interferon-γ on the activity of monocytes and monocyte-derived macrophages of AIDS patients against Toxoplasma gondii. Immunology 1994;83:646-50.
4. 2. AIDS 1995;9:441-5.
5. 2. Clin Exp Immunol 1995;102:425-9.
6. Langermans JAM, van der Hulst MEB, Nibbering PH, van Furth R. Activation of mouse peritoneal macrophages during infection with Salmonella typhimurium does not result in enhanced intracellular killing. J Immunol 1990;144:4340-6.
7. Agostini C, Trentin L, Zambello R et al. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation. J Immunol 1992; 149:3379-85.
8. Mooij P, Simons PJ, de Haan-Meulman M, de Wit HJ, Drexhage HA. Effect of thyroid hormones and other iodinated compounds on the transition of monocytes into veiled/dendritic cells: role of granulocyte-macrophage colony-stimulating factor, tumour-necrosis factor-α and interleukin-6. J Endocrinol 1994;140:503-12.
9. Clouse KA, Cosentino LM, Weih KA et al. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991;147:2892-901.
10. Molina JM, Schindler R, Ferriani R et al. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis 1990;161: 888-93.
11. Reddy MM, Grieco MH. Erythropoietin and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in sera of patients with HIV infection. Int J STD AIDS 1991;2:128-32.
12. Hober D, Ajana F, Petit MC et al. Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol Immunol 1993;37:785-92.
13. Murray HW, Rubin BY, Carriero SM, Harris AM, Jaffee EA. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent versus oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol 1985;134:1982-8.